A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer
Not Applicable
- Conditions
- Carcinoma, Hepatocellular
- Registration Number
- NCT00563095
- Lead Sponsor
- Hospital Authority, Hong Kong
- Brief Summary
Primary: To compare the efficacy of TACE and TAIE.
Secondary: To compare the side effects of TACE and TAIE.
The outcome measurements include survival benefit and tumour regression induced by the two therapies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Confirmed hepatocellular carcinoma not suitable for surgery
Exclusion Criteria
- Portal vein thrombosis
- Severe arteriovenous shunt
- Bilirubin level > 50 umol/mL
- Prothrombin time > 5 seconds
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method regression of tumour size assessment every 6 months
- Secondary Outcome Measures
Name Time Method side effects every treatment given every 8 - 12 weeks
Trial Locations
- Locations (1)
Queen Mary Hospital
🇨🇳Hong Kong, China